Valsartan NDC 65862-572

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-572Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0572Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
65862-572-10	65862057210	10 BLISTER PACK in 1 CARTON (65862-572-10) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Jan 5, 2015
65862-572-90	65862057290	90 TABLET, FILM COATED in 1 BOTTLE (65862-572-90)Marketed from Jan 5, 2015
65862-572-99	65862057299	1000 TABLET, FILM COATED in 1 BOTTLE (65862-572-99)Marketed from Jan 5, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Valsartan
Generic name (nonproprietary): valsartan
Active ingredients: Valsartan — 160 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Aurobindo Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202223
Marketing start: Jan 5, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 65862-572_7b329c09-5c17-4117-9cef-a383ecec90d9SPL ID 7b329c09-5c17-4117-9cef-a383ecec90d9SPL set ID a81a72dd-e828-4208-af9b-bb9ac4938537RxCUI 349199, 349200, 349201, 349483UNII 80M03YXJ7I
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862057210 followed by a unit qualifier and the quantity

Package 65862-0572-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 19, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Valsartan is an angiotensin II receptor blocker (ARB) indicated for: Hypertension , to lower blood pressure in adults and children 1 year and older. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions ( 1.1 ) Heart failure (NYHA class II to IV), to reduce hospitalization for heart failure in adults ( 1.2 ) Post-myocardial infarction, for the reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction in adults ( 1.3 ) 1.1 Hypertension Valsartan tablets are indicated for the treatment of hypertension, to lower bloo…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202223

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202223
Product	Strength	Form · route	Labeler	Product NDC
Valsartan	Valsartan 40 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-570
Valsartan	Valsartan 80 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-571
Valsartan	Valsartan 320 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-573